This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct. 2 poster presentation at the American Society for RadiationOncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. Amsbaugh; Catherine S.
Heisler Associate Professor for Lung Cancer Excellence, is the chair of the Cancer Communications Committee and an incoming elected member of the Nominating Committee; and Neha Vapiwala, MD, FASCO , a professor of RadiationOncology, is an elected member of the Nominating Committee. Also, Lynn M. CT in Room E451. CT in S100bc.
PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiationoncology community at ASTRO 2023,” said David E. PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Presenter: Ashesh B.
Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer, according to a study presented September 30 at the American Society for RadiationOncology (ASTRO) annual meeting. each year – are diagnosed as localized disease.
The guideline is published in Practical RadiationOncology. The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor.
A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for RadiationOncology (ASTRO) meeting.
Radiationoncology clinics face numerous challenges in the present environment, including the simultaneous management of multiple tasks (many of which are manual in nature), various degrees of standardisation, and the potential for errors to impact patient treatment. per week for curative diseases.
This special edition features presentations by MD Anderson researchers at the 2023 American Society for RadiationOncology (ASTRO) Annual Meeting. A new study presented by Aaron Seo, M.D., Seo will present the results on Oct. In a new study presented by Alexander Sherry, M.D.,
Findings will be presented today at the American Society for RadiationOncology (ASTRO) Annual Meeting. Allen, MD , a radiationoncology resident physician at the University of Maryland Medical Center in Baltimore. Black patients with prostate cancer in the U.S. and 34% Black, 3.2% Asian/Pacific Islander and 1.3%
milla1cf Mon, 05/15/2023 - 10:26 May 15, 2023 — GE HealthCare is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite) – that underscore the company’s commitment to enhancing the radiationoncology care pathway.
Findings will be presented today at the American Society for RadiationOncology (ASTRO) Annual Meeting. Earlier detection allows for earlier treatment of residual disease and potentially better survival rates. and an estimated 4,000 Americans die from the disease each year.
Head and neck cancer of “unknown primary” is a distinct group of highly heterogeneous malignancies, with patients typically presenting initially with enlarged cervical lymph nodes, the authors explained. but presented no evidence for primary tumor. (B) There was intensive uptake of Ga-68 FAPI in palate (red arrow, SUV max , 11.3). (C)
milla1cf Mon, 11/20/2023 - 12:49 November 20, 2023 — The American Society for RadiationOncology (ASTRO) issued a clinical guideline on partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ ( DCIS ).
Effective initial staging of prostate cancer, particularly with regards to the detection of metastatic disease, is critical to optimal clinical management of patients,” said Phillip H. Such information can help guide treatment selection and potentially avoid futile surgery for patients with high-risk disease.” “We
5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients with oligometastatic pancreatic cancer. assistant professor of Gastrointestinal RadiationOncology. “We
milla1cf Mon, 10/02/2023 - 13:30 October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests. and worldwide. and worldwide. Chaudhuri explained.
One of the biggest challenges of oncology care is the complexity of the disease - both in the many varieties of cancer, and the disparate ways it can present in each individual patient [ii] - requiring diligence and personalization in diagnosis and treatment.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiationoncology.
At the meeting, held from October 1 to October 4, 2023, in San Diego, Simon Powell, MD, PhD, FRCP , Chair of MSK’s Department of RadiationOncology and Enid A. Haupt Chair in RadiationOncology, was honored with ASTRO’s Gold Medal Award. These are some of the highlights.
The study – a randomized phase III clinical trial involving 10 countries across four continents – found delivering a course of radiation in 20 rather than 33 treatment sessions was just as effective at controlling cancer for patients with alcohol and tobacco-related, locally advanced disease, without increasing side effects.
Editor's note: As part of the celebration of AuntMinnie.com's upcoming 25th anniversary, we're presenting 25 for 25 -- a series featuring our most popular content for each of the last 25 years. New articles will be published each Monday until our official anniversary at RSNA 2024.
The findings, which are the latest from a series of studies investigating the benefits of stereotactic body radiation therapy (SBRT) for people diagnosed with prostate cancer, will be presented today at the American Society for RadiationOncology (ASTRO) Annual Meeting.
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content